To investigate the functions of HDAC1 and HDAC2 in CML, we used CRISPR/Cas9 to specifically gene edit HDAC1 and HDAC2 through lentivirus transfection of K562 cells. The gene discussed is HDAC2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.